Stocktoria

Aprea Therapeutics, Inc. APRE

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2019-10-03

Aprea Therapeutics, Inc. statistics & valuation

Market cap$9.8M
P / B0.8×
Return on equity-101.3%
Return on capital-100.5%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
20182019202020212022202320242025
Operating margin (%)
20182019202020212022202320242025
Return on equity (%)
-22.60% -69.10% -75.00% -439.30% -84.30% -67.10% -101.30% 20182019202020212022202320242025
Shares outstanding
1.2M 21.0M 21.2M 1.1M 2.7M 3.7M 5.5M 8.2M 20182019202020212022202320242025
Net debt ($)
20182019202020212022202320242025
Share buybacks ($)
20182019202020212022202320242025
Return on assets (%)
-23.50% -21.00% -57.60% -65.30% -373.60% -63.10% -54.00% -79.10% 20182019202020212022202320242025
Free cash flow margin (%)
20182019202020212022202320242025
Debt / equity (×)
20182019202020212022202320242025
EPS ($)
-$4.67 -$50.61 -$34.88 -$67.99 -$3.95 -$2.35 -$1.93 20182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Return on assets-79.1%-54.0%-63.1%-373.6%-65.3%-57.6%-21.0%-23.5%
Return on equity-101.3%-67.1%-84.3%-439.3%-75.0%-69.1%-22.6%30.2%
Current ratio5.637.015.149.427.736.0314.6813.56

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.